| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADE Eval: An Evaluation of Text Processing Systems for Adverse Event Extraction from Drug Labels for Pharmacovigilance
|
Bayer, Samuel
|
|
|
|
1 |
p. 83-94
|
artikel
|
| 2 |
Advances in the Pharmacogenomics of Adverse Drug Reactions
|
Collins, Susannah L.
|
|
2015
|
|
1 |
p. 15-27
|
artikel
|
| 3 |
Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding
|
Wunnava, Susmitha
|
|
2019
|
|
1 |
p. 113-122
|
artikel
|
| 4 |
Adverse Drug Events Detection in Clinical Notes by Jointly Modeling Entities and Relations Using Neural Networks
|
Dandala, Bharath
|
|
2019
|
|
1 |
p. 135-146
|
artikel
|
| 5 |
Adverse Drug Reactions to Gabapentin and Pregabalin
|
Fuzier, Régis
|
|
2012
|
|
1 |
p. 55-62
|
artikel
|
| 6 |
Aim and Design of pREGnant, the Dutch Pregnancy Drug Register
|
Vorstenbosch, Saskia
|
|
2018
|
|
1 |
p. 1-12
|
artikel
|
| 7 |
An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies
|
Maciá-Martínez, Miguel-Angel
|
|
2015
|
|
1 |
p. 29-43
|
artikel
|
| 8 |
An Intervention to Improve Spontaneous Adverse Drug Reaction Reporting by Hospital Physicians
|
Pedrós, Consuelo
|
|
2008
|
|
1 |
p. 77-83
|
artikel
|
| 9 |
Anticancer Drug—Induced Kidney Disorders
|
Kintzel, Polly E.
|
|
|
|
1 |
p. 19-38
|
artikel
|
| 10 |
Antidepressant-Induced Acute Liver Injury: A Case–Control Study in an Italian Inpatient Population
|
Ferrajolo, Carmen
|
|
2017
|
|
1 |
p. 95-102
|
artikel
|
| 11 |
Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy’s Law
|
Shen, Xin
|
|
2013
|
|
1 |
p. 43-51
|
artikel
|
| 12 |
An Update on ISoP Special Interest Groups (SIGs)
|
McCarthy, Deirdre
|
|
2017
|
|
1 |
p. 1-6
|
artikel
|
| 13 |
A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 Diabetes
|
Lui, David Tak Wai
|
|
|
|
1 |
p. 53-64
|
artikel
|
| 14 |
Application of an Innovative Data Mining Approach Towards Safe Polypharmacy Practice in Older Adults
|
Shi, Yi
|
|
|
|
1 |
p. 93-102
|
artikel
|
| 15 |
A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases
|
Coloma, Preciosa M.
|
|
2012
|
|
1 |
p. 13-23
|
artikel
|
| 16 |
A Risk-Benefit Assessment of Tacrine in the Treatment of Alzheimer’s Disease
|
Samuels, Steven C.
|
|
|
|
1 |
p. 66-77
|
artikel
|
| 17 |
Aristolochic Acid Nephropathy: Epidemiology, Clinical Presentation, and Treatment
|
Luciano, Randy L.
|
|
2014
|
|
1 |
p. 55-64
|
artikel
|
| 18 |
Artesunate- and Amodiaquine-Associated Extrapyramidal Reactions
|
Bompart, François
|
|
2012
|
|
1 |
p. 71-72
|
artikel
|
| 19 |
Assessment of Self-Administration of Romiplostim in Patients with Immune Thrombocytopenic Purpura after Receipt of Home Administration Training Materials: a Cross-Sectional Study
|
Schipperus, Martin
|
|
2018
|
|
1 |
p. 77-83
|
artikel
|
| 20 |
Authors’ Reply to Ahmad SR: “Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries”
|
Margraff, Florence
|
|
2014
|
|
1 |
p. 111
|
artikel
|
| 21 |
Author’s Reply to Bompart: “Artesunate- and Amodiaquine-Associated Extrapyramidal Reactions: Information Gained from an African-Based Risk Management Plan”
|
McEwen, John
|
|
2012
|
|
1 |
p. 73
|
artikel
|
| 22 |
Authors’ Reply to Harpaz et al. Comment on: “Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance”
|
Norén, G. Niklas
|
|
2014
|
|
1 |
p. 115-116
|
artikel
|
| 23 |
Authors’ Reply to Hennessy and Leonard’s Comment on “Desideratum for Evidence-Based Epidemiology”
|
Overhage, J. Marc
|
|
2014
|
|
1 |
p. 105-107
|
artikel
|
| 24 |
Authors’ Reply to Sibel Yöntem and Colleagues’ Comment on “Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case-Control Study in Haryana, India”
|
Neogi, Sutapa Bandyopadhyay
|
|
2015
|
|
1 |
p. 91-92
|
artikel
|
| 25 |
A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007–2019)
|
Perri-Plandé, Joelle
|
|
|
|
1 |
p. 37-44
|
artikel
|
| 26 |
Bacillus Calmette-Guérin (BCG) Vaccine Adverse Events in Victoria, Australia: Analysis of Reports to an Enhanced Passive Surveillance System
|
Clothier, Hazel J.
|
|
2014
|
|
1 |
p. 79-86
|
artikel
|
| 27 |
Benefit-Risk Assessment of Bevacizumab in the Treatment of Breast Cancer
|
Dienstmann, Rodrigo
|
|
2012
|
|
1 |
p. 15-25
|
artikel
|
| 28 |
Benefits and Risks of Antipsychotic Polypharmacy
|
Tranulis, Constantin
|
|
2008
|
|
1 |
p. 7-20
|
artikel
|
| 29 |
Benefits and Risks of Transfer from Oral Agents to Insulin in Type 2 Diabetes Mellitus
|
Evans, Alison
|
|
|
|
1 |
p. 7-22
|
artikel
|
| 30 |
Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis
|
Caldeira, Daniel
|
|
2017
|
|
1 |
p. 77-86
|
artikel
|
| 31 |
Cardiovascular Events in Patients taking Varenicline
|
Harrison-Woolrych, Mira
|
|
2012
|
|
1 |
p. 33-43
|
artikel
|
| 32 |
Causal Assessment of Pharmaceutical Treatments: Why Standards of Evidence Should not be the Same for Benefits and Harms?
|
Osimani, Barbara
|
|
2014
|
|
1 |
p. 1-11
|
artikel
|
| 33 |
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry
|
Simbrich, Alexandra
|
|
|
|
1 |
p. 7-15
|
artikel
|
| 34 |
Chronic Obstructive Pulmonary Disease Adverse Event Signals Associated with Potential Inhibitors of Glutathione Peroxidase 1: A Sequence Symmetry Analysis
|
Janetzki, Jack L.
|
|
|
|
1 |
p. 59-70
|
artikel
|
| 35 |
Cognitive Safety is Largely Ignored in Clinical Drug Trials: A Study of Registered Study Protocols
|
Reimers, Arne
|
|
|
|
1 |
p. 23-28
|
artikel
|
| 36 |
Comment on: “Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries”
|
Ahmad, Syed Rizwanuddin
|
|
2014
|
|
1 |
p. 109-110
|
artikel
|
| 37 |
Comment on: “Desideratum for Evidence-Based Epidemiology”
|
Hennessy, Sean
|
|
2014
|
|
1 |
p. 101-103
|
artikel
|
| 38 |
Comment on: “Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case–Control Study in Haryana, India”
|
Yöntem, Sibel
|
|
2015
|
|
1 |
p. 89-90
|
artikel
|
| 39 |
Comment on: “Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance”
|
Harpaz, Rave
|
|
2014
|
|
1 |
p. 113-114
|
artikel
|
| 40 |
Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
|
Patek, Taylor M.
|
|
|
|
1 |
p. 17-22
|
artikel
|
| 41 |
Comparing Time to Adverse Drug Reaction Signals in a Spontaneous Reporting Database and a Claims Database: A Case Study of Rofecoxib-Induced Myocardial Infarction and Rosiglitazone-Induced Heart Failure Signals in Australia
|
A.Wahab, Izyan
|
|
2013
|
|
1 |
p. 53-64
|
artikel
|
| 42 |
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®
|
Chandler, Rebecca E.
|
|
2016
|
|
1 |
p. 81-90
|
artikel
|
| 43 |
Data Resources for Investigating Drug Exposure during Pregnancy and Associated Outcomes
|
Charlton, Rachel A.
|
|
2008
|
|
1 |
p. 39-51
|
artikel
|
| 44 |
Deaths from Medicines: A Systematic Analysis of Coroners’ Reports to Prevent Future Deaths
|
Ferner, Robin E.
|
|
2017
|
|
1 |
p. 103-110
|
artikel
|
| 45 |
Detecting Adverse Drug Events with Rapidly Trained Classification Models
|
Chapman, Alec B.
|
|
2019
|
|
1 |
p. 147-156
|
artikel
|
| 46 |
Determinants of Under-Reporting of Adverse Drug Reactions
|
Lopez-Gonzalez, Elena
|
|
2008
|
|
1 |
p. 19-31
|
artikel
|
| 47 |
Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms’ Fit for Purpose for Safety Outcomes
|
Singh, Sonal
|
|
|
|
1 |
p. 87-97
|
artikel
|
| 48 |
Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors
|
Hoeve, Christina E.
|
|
|
|
1 |
p. 73-82
|
artikel
|
| 49 |
Dopamine Agonists and Impulse Control Disorders: A Complex Association
|
Grall-Bronnec, Marie
|
|
2017
|
|
1 |
p. 19-75
|
artikel
|
| 50 |
Drug Administration in Chronic Liver Disease
|
Westphal, Jean-Frédéric
|
|
|
|
1 |
p. 47-73
|
artikel
|
| 51 |
Drug-Induced Liver Injury Network (DILIN) Prospective Study
|
Fontana, Robert J.
|
|
2008
|
|
1 |
p. 55-68
|
artikel
|
| 52 |
Drug-Induced Musculoskeletal Disorders
|
Bannwarth, Bernard
|
|
|
|
1 |
p. 27-46
|
artikel
|
| 53 |
Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?
|
Hondeghem, Luc M.
|
|
2017
|
|
1 |
p. 11-17
|
artikel
|
| 54 |
Drug-Induced Thrombocytopenia
|
Swisher, Karen K.
|
|
2008
|
|
1 |
p. 85-86
|
artikel
|
| 55 |
Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations
|
Peters, Tanja
|
|
|
|
1 |
p. 17-28
|
artikel
|
| 56 |
Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration’s Adverse Event Reporting System
|
Rogers, James R.
|
|
2018
|
|
1 |
p. 85-93
|
artikel
|
| 57 |
Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson’s Disease Dementia
|
Oertel, Wolfgang
|
|
2008
|
|
1 |
p. 79-94
|
artikel
|
| 58 |
Efficacy and Safety of Bevacizumab Plus Oxaliplatin- or Irinotecan-Based Doublet Backbone Chemotherapy as the First-Line Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis
|
Ren, Tianshu
|
|
|
|
1 |
p. 29-40
|
artikel
|
| 59 |
Enrollment and Retention in 34 United States Pregnancy Registries Contrasted with the Manufacturer’s Capture of Spontaneous Reports for Exposed Pregnancies
|
Bird, Steven T.
|
|
2017
|
|
1 |
p. 87-94
|
artikel
|
| 60 |
Erratum to Cisparide: drug interactions of clinical significance
|
Bedford, T. A.
|
|
1997
|
|
1 |
p. 36
|
artikel
|
| 61 |
EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars
|
Calvo, Begoña
|
|
2013
|
|
1 |
p. 9-18
|
artikel
|
| 62 |
Evaluating the Safety Profile of Non-Active Implantable Medical Devices Compared with Medicines
|
Pane, Josep
|
|
2016
|
|
1 |
p. 37-47
|
artikel
|
| 63 |
Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China
|
Yang, Yu
|
|
2017
|
|
1 |
p. 125-137
|
artikel
|
| 64 |
Experiences with Adverse Drug Reaction Reporting by Patients
|
Hunsel, Florence van
|
|
2012
|
|
1 |
p. 45-60
|
artikel
|
| 65 |
Experiences with Adverse Drug Reaction Reporting by Patients
|
van Hunsel, Florence
|
|
|
|
1 |
p. 45-60
|
artikel
|
| 66 |
Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records
|
Banda, Juan M.
|
|
2015
|
|
1 |
p. 45-57
|
artikel
|
| 67 |
Follow-up on the Use of Advanced Analytics for Clinical Quality Assurance: Bootstrap Resampling to Enhance Detection of Adverse Event Under-Reporting
|
Koneswarakantha, Björn
|
|
|
|
1 |
p. 121-123
|
artikel
|
| 68 |
Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System
|
Trumbo, Henry
|
|
|
|
1 |
p. 107-119
|
artikel
|
| 69 |
Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety Analysis
|
Vir Singh, Puneet
|
|
|
|
1 |
p. 99-108
|
artikel
|
| 70 |
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective
|
Beyzarov, Elena
|
|
|
|
1 |
p. 95-105
|
artikel
|
| 71 |
Glucose-6-Phosphate Dehydrogenase Deficiency and Safety of Methylene Blue
|
Müller, Olaf
|
|
2012
|
|
1 |
p. 85
|
artikel
|
| 72 |
Guidelines for Monitoring Patients Taking Tamoxifen Treatment
|
Neven, Patrick
|
|
|
|
1 |
p. 1-11
|
artikel
|
| 73 |
Hepatotoxicity of Antiretrovirals
|
Núñez, Marina
|
|
|
|
1 |
p. 53-66
|
artikel
|
| 74 |
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
|
Shakir, Saad
|
|
|
|
1 |
p. 1-5
|
artikel
|
| 75 |
Hybrid Method Incorporating a Rule-Based Approach and Deep Learning for Prescription Error Prediction
|
Lee, Seunghee
|
|
|
|
1 |
p. 27-35
|
artikel
|
| 76 |
Identifying Adverse Events of Vaccines Using a Bayesian Method of Medically Guided Information Sharing
|
Crooks, Colin John
|
|
2012
|
|
1 |
p. 61-78
|
artikel
|
| 77 |
Implementation of the Harmonized EU Isotretinoin Pregnancy Prevention Programme
|
Crijns, Ineke
|
|
2012
|
|
1 |
p. 27-32
|
artikel
|
| 78 |
Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks
|
van Stekelenborg, John
|
|
|
|
1 |
p. 39-52
|
artikel
|
| 79 |
Industry Review of Best Practices for Risk Management of Drug-Induced Liver Injury from Development to Real-World Use
|
Marquez, Loreta
|
|
|
|
1 |
p. 1-22
|
artikel
|
| 80 |
Intelligent Risk Communication
|
Czarnecki, Andrzej
|
|
2008
|
|
1 |
p. 1-6
|
artikel
|
| 81 |
Intravenous Medication Administration Safety with Smart Infusion Pumps in the Neonatal Intensive Care Unit: An Observational Study
|
Schnock, Kumiko O.
|
|
|
|
1 |
p. 29-38
|
artikel
|
| 82 |
Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe
|
Francisca, Reynold D. C.
|
|
|
|
1 |
p. 63-72
|
artikel
|
| 83 |
Key Elements in Adverse Drug Interaction Safety Signals
|
Strandell, Johanna
|
|
2012
|
|
1 |
p. 63-70
|
artikel
|
| 84 |
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis
|
Strober, Bruce
|
|
|
|
1 |
p. 39-57
|
artikel
|
| 85 |
MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes
|
Yang, Xi
|
|
2019
|
|
1 |
p. 123-133
|
artikel
|
| 86 |
Maternal Recall of Prescription Medication Use During Pregnancy Using a Paper-Based Questionnaire
|
Gelder, Marleen M. H. J. van
|
|
2012
|
|
1 |
p. 43-54
|
artikel
|
| 87 |
Methods for Causality Assessment of Adverse Drug Reactions
|
Agbabiaka, Taofikat B.
|
|
2008
|
|
1 |
p. 21-37
|
artikel
|
| 88 |
Nonsteroidal Anti-Inflammatory Drugs and Risk of First Hospitalization for Heart Failure in Patients with No History of Heart Failure: A Population-Based Case-Crossover Study
|
Huang, Sung-Po
|
|
2018
|
|
1 |
p. 67-75
|
artikel
|
| 89 |
Ongoing Challenges in Pharmacovigilance
|
Dal Pan, Gerald J.
|
|
2013
|
|
1 |
p. 1-8
|
artikel
|
| 90 |
On the Potential of Preemptive Genotyping Towards Preventing Medication-Related Adverse Events: Results from the South Korean National Health Insurance Database
|
Schildcrout, Jonathan S.
|
|
2016
|
|
1 |
p. 1-2
|
artikel
|
| 91 |
Opportunities to Reduce Medication Regimen Complexity
|
Witticke, Diana
|
|
2012
|
|
1 |
p. 31-41
|
artikel
|
| 92 |
Optimal Glycaemic Control in Elderly People with Type 2 Diabetes: What Does the Evidence Say?
|
Mathur, Supriya
|
|
2014
|
|
1 |
p. 17-32
|
artikel
|
| 93 |
Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience
|
Oosterhuis, Ingrid
|
|
|
|
1 |
p. 65-75
|
artikel
|
| 94 |
Orlistat-Associated Adverse Effects and Drug Interactions
|
Filippatos, Theodosios D.
|
|
2008
|
|
1 |
p. 53-65
|
artikel
|
| 95 |
Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0)
|
Jagannatha, Abhyuday
|
|
2019
|
|
1 |
p. 99-111
|
artikel
|
| 96 |
Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media
|
Micale, Cristina
|
|
|
|
1 |
p. 81-91
|
artikel
|
| 97 |
Patient Safety Incidents Related to the Use of Parenteral Nutrition in All Patient Groups: A Systematic Scoping Review
|
Mistry, Priya
|
|
|
|
1 |
p. 1-18
|
artikel
|
| 98 |
Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort Study
|
Mathieu, Clément
|
|
|
|
1 |
p. 53-62
|
artikel
|
| 99 |
Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature
|
Way, Dominic
|
|
2016
|
|
1 |
p. 15-36
|
artikel
|
| 100 |
Pharmacovigilance in the Middle East
|
Wilbur, Kerry
|
|
2012
|
|
1 |
p. 25-30
|
artikel
|
| 101 |
Pharmacovigilance of Herbal Medicines
|
Rodrigues, Eliana
|
|
2012
|
|
1 |
p. 1-12
|
artikel
|
| 102 |
Platelet Measurements versus Discharge Diagnoses for Identification of Patients with Potential Drug-Induced Thrombocytopenia
|
Berg, Maarten J. ten
|
|
2008
|
|
1 |
p. 69-76
|
artikel
|
| 103 |
POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure
|
Benevent, Justine
|
|
2018
|
|
1 |
p. 45-54
|
artikel
|
| 104 |
Post-Approval Evaluation of Effectiveness of Risk Minimisation: Methods, Challenges and Interpretation
|
Banerjee, Anjan Kumar
|
|
2013
|
|
1 |
p. 33-42
|
artikel
|
| 105 |
Potential Risk Factors of Drug-Related Problems in Hospital-Based Mental Health Units: A Systematic Review
|
Alshaikhmubarak, Fatima Q.
|
|
|
|
1 |
p. 19-37
|
artikel
|
| 106 |
Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023
|
Alexander, G. Caleb
|
|
|
|
1 |
p. 103-111
|
artikel
|
| 107 |
Proton Pump Inhibitors and Risk of Rhabdomyolysis
|
Duncan, Scott J.
|
|
2016
|
|
1 |
p. 61-64
|
artikel
|
| 108 |
Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase®
|
Aldea Perona, Ana
|
|
2015
|
|
1 |
p. 69-78
|
artikel
|
| 109 |
Randomized, Double-Blind, Crossover Study to Investigate the Effect of Rivaroxaban on QT-Interval Prolongation
|
Kubitza, Dagmar
|
|
2008
|
|
1 |
p. 67-77
|
artikel
|
| 110 |
RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability
|
Nadal, Ernest
|
|
|
|
1 |
p. 45-64
|
artikel
|
| 111 |
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Acute Pancreatitis: A Population-Based Cohort Study
|
Rouette, Julie
|
|
|
|
1 |
p. 65-74
|
artikel
|
| 112 |
Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures
|
Nathell, Lennart
|
|
|
|
1 |
p. 35-43
|
artikel
|
| 113 |
Reversal Strategies for NOACs: State of Development, Possible Clinical Applications and Future Perspectives
|
Husted, Steen
|
|
2015
|
|
1 |
p. 5-13
|
artikel
|
| 114 |
Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean Patients
|
Kim, Grace Juyun
|
|
2016
|
|
1 |
p. 65-80
|
artikel
|
| 115 |
Role of Viral Infections in the Induction of Adverse Drug Reactions
|
Levy, Micha
|
|
|
|
1 |
p. 1-8
|
artikel
|
| 116 |
Safety Considerations with Pharmacological Treatment of Gestational Diabetes Mellitus
|
Simmons, David
|
|
2014
|
|
1 |
p. 65-78
|
artikel
|
| 117 |
Safety of Hepatitis B, Pneumococcal Polysaccharide and Meningococcal Polysaccharide Vaccines in Pregnancy
|
Makris, Marinos C.
|
|
2012
|
|
1 |
p. 1-14
|
artikel
|
| 118 |
Safety of Intravenous Push Levetiracetam Compared to Intravenous Piggyback at a Tertiary Academic Medical Center: A Retrospective Analysis
|
Alkazemi, Afrah
|
|
|
|
1 |
p. 19-26
|
artikel
|
| 119 |
Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis
|
Valero, Antonio
|
|
2008
|
|
1 |
p. 33-42
|
artikel
|
| 120 |
Setting Standards for Pregnancy Registries
|
Holmes, Lewis B.
|
|
2017
|
|
1 |
p. 7-9
|
artikel
|
| 121 |
Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis
|
Reichenpfader, Ursula
|
|
2013
|
|
1 |
p. 19-31
|
artikel
|
| 122 |
Should Antidepressants be Avoided in Pregnancy?
|
Besag, Frank M. C.
|
|
|
|
1 |
p. 1-17
|
artikel
|
| 123 |
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case–Control Study
|
Frey, Noel
|
|
2018
|
|
1 |
p. 55-66
|
artikel
|
| 124 |
Structured Assessment for Prospective Identification of Safety Signals in Electronic Medical Records: Evaluation in the Health Improvement Network
|
Cederholm, S.
|
|
2014
|
|
1 |
p. 87-100
|
artikel
|
| 125 |
Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres
|
Kant, Agnes
|
|
2018
|
|
1 |
p. 35-43
|
artikel
|
| 126 |
Terminological Challenges in Safety Surveillance
|
Bate, Andrew
|
|
2012
|
|
1 |
p. 79-84
|
artikel
|
| 127 |
The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study
|
Stelt, C. A. K. van der
|
|
2015
|
|
1 |
p. 79-87
|
artikel
|
| 128 |
The Authors’ Reply
|
Youngster, Ilan
|
|
2012
|
|
1 |
p. 85-86
|
artikel
|
| 129 |
The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases
|
Abraham, Hazel Mae A.
|
|
2014
|
|
1 |
p. 33-54
|
artikel
|
| 130 |
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project
|
Raschi, Emanuel
|
|
2015
|
|
1 |
p. 59-68
|
artikel
|
| 131 |
The Harms of Antipsychotic Drugs: Evidence from Key Studies
|
Moore, Thomas J.
|
|
2016
|
|
1 |
p. 3-14
|
artikel
|
| 132 |
The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions
|
Candore, Gianmario
|
|
|
|
1 |
p. 83-95
|
artikel
|
| 133 |
The Prevalence of Dose Errors Among Paediatric Patients in Hospital Wards with and without Health Information Technology: A Systematic Review and Meta-Analysis
|
Gates, Peter J.
|
|
2018
|
|
1 |
p. 13-25
|
artikel
|
| 134 |
The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study
|
Kassie, Gizat M.
|
|
|
|
1 |
p. 75-82
|
artikel
|
| 135 |
The Role of Hemoglobin Laboratory Test Results for the Detection of Upper Gastrointestinal Bleeding Outcomes Resulting from the Use of Medications in Observational Studies
|
Patorno, Elisabetta
|
|
2016
|
|
1 |
p. 91-100
|
artikel
|
| 136 |
The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database
|
Castillon, Genaro
|
|
2018
|
|
1 |
p. 27-34
|
artikel
|
| 137 |
The TESS Database
|
Litovitz, Toby
|
|
|
|
1 |
p. 9-19
|
artikel
|
| 138 |
The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance
|
Osborne, Vicki
|
|
2017
|
|
1 |
p. 139-141
|
artikel
|
| 139 |
The US Food and Drug Administration-European Medicines Agency Collaboration in Pharmacovigilance: Common Objectives and Common Challenges
|
Dal Pan, Gerald J.
|
|
2014
|
|
1 |
p. 13-15
|
artikel
|
| 140 |
Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records
|
Liu, Feifan
|
|
2019
|
|
1 |
p. 95-97
|
artikel
|
| 141 |
Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient’s Quality of Life: A Single-Center, 10-Year Experience from Southern Italy
|
Oteri, Giacomo
|
|
2017
|
|
1 |
p. 111-123
|
artikel
|
| 142 |
Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa
|
Mehta, Ushma
|
|
|
|
1 |
p. 41-51
|
artikel
|
| 143 |
Use and Risk Management of Carvedilol for the Treatment of Heart Failure in the Community in England
|
Aurich-Barrera, Beate
|
|
2008
|
|
1 |
p. 43-54
|
artikel
|
| 144 |
Validation of a Natural Language Machine Learning Model for Safety Literature Surveillance
|
Park, Jiyoon
|
|
|
|
1 |
p. 71-80
|
artikel
|
| 145 |
Vancomycin-Induced Thrombocytopenia: A Narrative Review
|
Mohammadi, Mehdi
|
|
2016
|
|
1 |
p. 49-59
|
artikel
|
| 146 |
vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues
|
Bergvall, Tomas
|
|
2013
|
|
1 |
p. 65-77
|
artikel
|
| 147 |
Vision Disorders and Phosphodiesterase Type 5 Inhibitors
|
Laties, Alan M.
|
|
2008
|
|
1 |
p. 1-18
|
artikel
|
| 148 |
Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase®
|
Kaguelidou, Florentia
|
|
|
|
1 |
p. 77-85
|
artikel
|
| 149 |
What Is the Plural of a ‘Yellow’ Anecdote?
|
Evans, Stephen J. W.
|
|
2015
|
|
1 |
p. 1-3
|
artikel
|
Tijdschrift beschrijving